These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36819564)

  • 1. Comparisons of the diagnostic accuracy of the ultrasonic sign-score method and MRI for PA, PI and PP in high-risk gravid women: a retrospective study.
    Ye C; Ling L; Li S; Zhang Z; Zhang X
    Ann Transl Med; 2023 Jan; 11(2):81. PubMed ID: 36819564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percreta score to differentiate between placenta accreta and placenta percreta with ultrasound and MR imaging.
    Pain FA; Dohan A; Grange G; Marcellin L; Uzan-Augui J; Goffinet F; Soyer P; Tsatsaris V
    Acta Obstet Gynecol Scand; 2022 Oct; 101(10):1135-1145. PubMed ID: 35822244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of Magnetic Resonance Imaging in diagnosis and assessment the depth of invasion of placental accreta in high risk gravid women.
    Khalaf LMR; Zeid HA; Othman ER
    Clin Imaging; 2019; 58():5-11. PubMed ID: 31212062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interobserver agreement in MRI assessment of severity of placenta accreta spectrum disorders.
    Finazzo F; D'antonio F; Masselli G; Forlani F; Palacios-Jaraquemada J; Minneci G; Gambarini S; Timor-Tritsch I; Prefumo F; Buca D; Liberati M; Khalil A; Cali G
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):467-473. PubMed ID: 31237043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraplacental T2-hypointense bands may help predict placental invasion depth and postpartum hemorrhage in placenta accrete spectrum disorders in high-risk gravid patients.
    Hu Y; Wang Y; Weng Q; Wu X; Xia S; Wang H; Cheng X; Mao C; Li X; Zhou Z; Chen C; Xu M; Wang Z; Ji J
    Magn Reson Imaging; 2022 Dec; 94():73-79. PubMed ID: 36116713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis.
    Familiari A; Liberati M; Lim P; Pagani G; Cali G; Buca D; Manzoli L; Flacco ME; Scambia G; D'antonio F
    Acta Obstet Gynecol Scand; 2018 May; 97(5):507-520. PubMed ID: 29136274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraplacental Fetal Vessel Diameter May Help Predict for Placental Invasiveness in Pregnant Women at High Risk for Placenta Accreta Spectrum Disorders.
    Bourgioti C; Konstantinidou AE; Zafeiropoulou K; Antoniou A; Fotopoulos S; Theodora M; Daskalakis G; Nikolaidou ME; Tzavara C; Letsika A; Martzoukos EA; Moulopoulos LA
    Radiology; 2021 Feb; 298(2):403-412. PubMed ID: 33231529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of placenta accreta spectrum in patients with placenta previa using clinical risk factors, ultrasound and magnetic resonance imaging findings.
    Romeo V; Verde F; Sarno L; Migliorini S; Petretta M; Mainenti PP; D'Armiento M; Guida M; Brunetti A; Maurea S
    Radiol Med; 2021 Sep; 126(9):1216-1225. PubMed ID: 34156592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive placenta previa: Placental bulge with distorted uterine outline and uterine serosal hypervascularity at 1.5T MRI - useful features for differentiating placenta percreta from placenta accreta.
    Chen X; Shan R; Zhao L; Song Q; Zuo C; Zhang X; Wang S; Shi H; Gao F; Qian T; Wang G; Limperopoulos C
    Eur Radiol; 2018 Feb; 28(2):708-717. PubMed ID: 28770405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between 1.5-T and 3.0-T MRI for the diagnosis of placenta accreta spectrum disorders.
    Bourgioti C; Zafeiropoulou K; Tzavara C; Daskalakis G; Fotopoulos S; Theodora M; Nikolaidou ME; Konidari M; Gourtsoyianni S; Panourgias E; Koutoulidis V; Martzoukos EA; Konstantinidou AE; Moulopoulos LA
    Diagn Interv Imaging; 2022 Sep; 103(9):408-417. PubMed ID: 35568666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Ultrasound and MRI in Diagnosis of Severe Placenta Accreta Spectrum Disorder: An Intraindividual Assessment With Emphasis on Placental Bulge.
    Thiravit S; Ma K; Goldman I; Chanprapaph P; Jha P; Hippe DS; Dighe M
    AJR Am J Roentgenol; 2021 Dec; 217(6):1377-1388. PubMed ID: 34037411
    [No Abstract]   [Full Text] [Related]  

  • 12. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
    Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Utility of the Prenatal Ultrasound Score of the Placenta Combined with Magnetic Resonance Imaging in Diagnosis of Placenta Accreta during the Second and Third Trimester of Pregnancy.
    Zhang J; Dong P
    Contrast Media Mol Imaging; 2022; 2022():9462139. PubMed ID: 35821890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a scoring system for prediction of obstetric complications in placenta accreta spectrum disorders.
    Zheng W; Zhang H; Ma J; Dou R; Zhao X; Yan J; Yang H
    J Matern Fetal Neonatal Med; 2022 Nov; 35(21):4149-4155. PubMed ID: 33685330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factor assessment and adverse outcome prediction of placenta accreta in pregnant women after cesarean section complicated with placenta previa: a national multicenter retrospective study].
    Bai GQ; Chen WL; Huang XH; Zhao SJ; Zhao SP; Chen XJ; Chen SW; Yang H; Lu X; Liu GY; Chen QH; Zhang LA; Jin L
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):26-36. PubMed ID: 36720612
    [No Abstract]   [Full Text] [Related]  

  • 16. Value of first-trimester ultrasound in prediction of third-trimester sonographic stage of placenta accreta spectrum disorder and surgical outcome.
    Calí G; Timor-Tritsch IE; Forlani F; Palacios-Jaraquemada J; Monteagudo A; Kaelin Agten A; Flacco ME; Khalil A; Buca D; Manzoli L; Liberati M; D'Antonio F
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):450-459. PubMed ID: 31788885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning analysis of MRI-derived texture features to predict placenta accreta spectrum in patients with placenta previa.
    Romeo V; Ricciardi C; Cuocolo R; Stanzione A; Verde F; Sarno L; Improta G; Mainenti PP; D'Armiento M; Brunetti A; Maurea S
    Magn Reson Imaging; 2019 Dec; 64():71-76. PubMed ID: 31102613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI prognosticators for adverse maternal and neonatal clinical outcome in patients at high risk for placenta accreta spectrum (PAS) disorders.
    Bourgioti C; Zafeiropoulou K; Fotopoulos S; Nikolaidou ME; Theodora M; Daskalakis G; Tzavara C; Chatoupis K; Panourgias E; Antoniou A; Konstantinidou A; Moulopoulos LA
    J Magn Reson Imaging; 2019 Aug; 50(2):602-618. PubMed ID: 30578609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying magnetic resonance imaging features to classify placenta accreta spectrum (PAS) in high-risk gravid patients.
    Chu C; Liu M; Zhang Y; Yu L; Wang D; Gao C; Li W
    Clin Imaging; 2021 Dec; 80():50-57. PubMed ID: 34242814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of magnetic resonance imaging in the diagnosis of placenta accreta.
    Niu L; Cui W; Zhu C; Lu X; Wang Y; Wang F
    Curr Med Imaging; 2023 Jun; ():. PubMed ID: 37366359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.